Impaired GH/IGF-1 axis [27, 35] and decreased bone turnover during the period of skeletal growth in adolescents with type 1 diabetes may attenuate formation during this period of bone growth [46–48]. This evidence concerns the gene IGF1 and type 1 diabetes mellitus.